Citations (108)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Roland Andersson & Bobby Tingstedt. (2023) Neoadjuvant chemo(radio)therapy in upfront resectable pancreatic cancer – can we stratify patients better in the future?. Scandinavian Journal of Gastroenterology 58:1, pages 1-2.
Read now
Read now
Roland Andersson, Caj Haglund, Hanna Seppänen & Daniel Ansari. (2022) Pancreatic cancer – the past, the present, and the future. Scandinavian Journal of Gastroenterology 57:10, pages 1169-1177.
Read now
Read now
Yasi Xing, Xinfa Zhang, Fangyuan Qin, Jingwen Yang, Lei Ai, Qingsong Wang & Yaping Zhai. (2022) The clinical significance of circulating tumor cells and T lymphocyte subtypes in pancreatic cancer patients. Bioengineered 13:2, pages 2128-2136.
Read now
Read now
Ya-Hui Chen, Yi-Chun Chen, Chi-Chen Lin, Yao-Peng Hsieh, Chien-Sheng Hsu & Ming-Chia Hsieh. (2020) Synergistic Anticancer Effects of Gemcitabine with Pitavastatin on Pancreatic Cancer Cell Line MIA PaCa-2 in vitro and in vivo. Cancer Management and Research 12, pages 4645-4665.
Read now
Read now
Louise Skau Rasmussen, Benny Vittrup, Morten Ladekarl, Per Pfeiffer, Mette Karen Yilmaz, Laurids Østergaard Poulsen, Kell Østerlind, Carsten Palnæs Hansen, Michael Bau Mortensen, Frank Viborg Mortensen, Mogens Sall, Sönke Detlefsen, Martin Bøgsted & Claus Wilki Fristrup. (2019) The effect of postoperative gemcitabine on overall survival in patients with resected pancreatic cancer: A nationwide population-based Danish register study. Acta Oncologica 58:6, pages 864-871.
Read now
Read now
Anna Nurmi, Harri Mustonen, Helka Parviainen, Katriina Peltola, Caj Haglund & Hanna Seppänen. (2018) Neoadjuvant therapy offers longer survival than upfront surgery for poorly differentiated and higher stage pancreatic cancer. Acta Oncologica 57:6, pages 799-806.
Read now
Read now
Bengt Glimelius. (2018) More than 1000 new manuscripts in 2017. Acta Oncologica 57:2, pages 174-175.
Read now
Read now
Bengt Glimelius. (2016) Any progress in pancreatic cancer?. Acta Oncologica 55:3, pages 255-258.
Read now
Read now
Articles from other publishers (100)
Jianhong An, Dacheng Xie & Keping Xie. (2023) Making incurable pancreatic cancer curable. Malignancy Spectrum.
Crossref
Crossref
Jakob Kirkegård, Morten Ladekarl, Andrea Lund & Frank Mortensen. (2023) Impact on Survival of Early Versus Late Initiation of Adjuvant Chemotherapy After Pancreatic Adenocarcinoma Surgery: A Target Trial Emulation. Annals of Surgical Oncology.
Crossref
Crossref
Yun Sun Lee, Hyung Sun Kim, Hyo Jung Kim, Hyeon Woong Kang, Da Eun Lee, Myeong Jin Kim, Woosol Chris Hong, Ju Hyun Kim, Minsoo Kim, Jae-Ho Cheong & Joon Seong Park. (2023) The role of LOXL2 induced by glucose metabolism-activated NF-κB in maintaining drug resistance through EMT and cancer stemness in gemcitabine-resistant PDAC. Journal of Molecular Medicine 101:11, pages 1449-1464.
Crossref
Crossref
Victoria S. Wu, Mohamedraed Elshami, Henry J. Stitzel, Jonathan J. Lee, Jonathan J. Hue, Ravi K. Kyasaram, Jeffrey M. Hardacre, John B. Ammori, Jordan M. Winter, Jennifer Eva Selfridge, Amr Mohamed, Sakti Chakrabarti, David Bajor, Amit Mahipal & Lee M. Ocuin. (2023) Why the Treatment Sequence Matters. Annals of Surgery 278:4, pages e677-e684.
Crossref
Crossref
Thomas B. Russell, Peter L. Labib, Fabio Ausania, Elizabeth Pando, Keith J. Roberts, Ambareen Kausar, Vasileios K. Mavroeidis, Gabriele Marangoni, Sarah C. Thomasset, Adam E. Frampton, Pavlos Lykoudis, Manuel Maglione, Nassir Alhaboob, Hassaan Bari, Andrew M. Smith, Duncan Spalding, Parthi Srinivasan, Brian R. Davidson, Ricky H. Bhogal, Daniel Croagh, Ismael Dominguez, Rohan Thakkar, Dhanny Gomez, Michael A. Silva, Pierfrancesco Lapolla, Andrea Mingoli, Alberto Porcu, Nehal S. Shah, Zaed Z.R. Hamady, Bilal Al-Sarrieh, Alejandro Serrablo, Somaiah Aroori, Peter L. Labib, Thomas B. Russell, Adam Streeter, Jemimah Denson, Mark Puckett, Shang-Ming Zhou, Matthew Browning, Somaiah Aroori, Fabio Ausania, Elizabeth Pando, Keith Roberts, Ambareen Kausar, Vasileios K. Mavroeidis, Gabriele Marangoni, Sarah Thomasset, Adam Frampton, Pavlos Lykoudis, Manuel Maglione, Nassir Alhaboob, Hassaan Bari, Andrew Smith, Duncan Spalding, Parthi Srinivasan, Brian Davidson, Ricky Bhogal, Daniel Croagh, Ismael Dominguez, Rohan Thakkar, Dhanny Gomez, Michael Silva, Pierfrancesco Lapolla, Andrea Mingoli, Alberto Porcu, Nehal Sureshkumar Shah, Zaed Hamady, Bilal Al-Sarrieh, Alejandro Serrablo, Carolina Gonzalez-Abos, Nair Fernandes, Elsa Garcia Moller, Cristina Dopazo Taboada, Rupaly Pande, Jameel Alfarah, Samik Bandyopadhyay, Ahmed Abdelrahim, Ayesha Khan, Caitlin Jordan, Jonathan R.E. Rees, Harry Blege, William Cambridge, Olga White, Sarah Blacker, Jessie Blackburn, Casie Sweeney, Daniel Field, Mohammed Gouda, Ruben Bellotti, Hytham K.S. Hamid, Hassan Ahmed, Catherine Moriarty, Louise White, Mark Priestley, Kerry Bode, Judith Sharp, Rosie Wragg, Beverley Jackson, Samuel Craven, Matyas Fehervari, Madhava Pai, Laith Alghazawi, Anjola Onifade, Julliette Ribaud, Ashitha Nair, Michael Mariathasan, Niamh Grayson, Stephanos Pericleous, Krishna Patel, Conrad Shaw, Nolitha Morare, Mohamad Khish Zaban, Joseph Doyle, Vasileios K. Mavroeidis, Alan Guerrero, Andre Moguel, Carlos Chan, Michael Jones, Edward Buckley, Nasreen Akter, Kyle Treherne, Gregory Gordon, Daniel Hughes, Tomas Urbonas, Gioia Brachini, Roberto Caronna, Piero Chirletti, Teresa Perra, Nurul Nadhirah Abd Kahar, Thomas Hall, Nabeegh Nadeem, Shoura Karar, Ali Arshad, Adam Yarwood, Mohammed Hammoda, Maria Artigas & Sandra Paterna-López. (2023) Serious complications of pancreatoduodenectomy correlate with lower rates of adjuvant chemotherapy: Results from the recurrence after Whipple's (RAW) study. European Journal of Surgical Oncology 49:9, pages 106919.
Crossref
Crossref
Anish J. Jain, Jessica E. Maxwell, Matthew H. G. Katz & Rebecca A. Snyder. (2023) Surgical Considerations for Neoadjuvant Therapy for Pancreatic Adenocarcinoma. Cancers 15:16, pages 4174.
Crossref
Crossref
Nicole Lintern, Andrew M. Smith, David G. Jayne & Yazan S. Khaled. (2023) Photodynamic Stromal Depletion in Pancreatic Ductal Adenocarcinoma. Cancers 15:16, pages 4135.
Crossref
Crossref
Thierry Conroy, Aurélien Lambert & Michel Ducreux. (2023) Adjuvant and neoadjuvant approaches in pancreatic cancer. Current Opinion in Oncology 35:4, pages 326-333.
Crossref
Crossref
Susanna W. L. de Geus & Teviah E. Sachs. (2023) A Paradigm Shifts: Neoadjuvant Therapy for Clearly Resectable Pancreatic Cancer. Annals of Surgical Oncology 30:6, pages 3427-3436.
Crossref
Crossref
Minoru Oshima, Keiichi Okano, Hideki Kamada, Hironobu Suto, Yasuhisa Ando, Emi Ibuki, Ryo Ishikawa, Tsutomu Masaki, Reiji Haba & Yasuyuki Suzuki. (2022)
P53
immunolabeling in
EUS‐FNA
biopsy can predict low resection rate and early recurrence in resectable or borderline resectable pancreatic cancer treated with neoadjuvant therapy
. Journal of Hepato-Biliary-Pancreatic Sciences 30:6, pages 802-814.
Crossref
Crossref
Jaewoo Kwon, Sung Ryol Lee, Seo Young Park, Jae Hoon Lee, Ki Byung Song, Dae Wook Hwang, Jun Ho Shin & Song Cheol Kim. (2022) Effect of resection margin status on recurrence pattern and survival in distal pancreatectomy for left‐sided pancreatic ductal adenocarcinoma. Journal of Hepato-Biliary-Pancreatic Sciences 30:5, pages 633-643.
Crossref
Crossref
Alexandre Thobie, Fabien Robin, Benjamin Menahem, Jean Lubrano, Karim Boudjema, Arnaud Alves, Olivier Dejardin & Laurent Sulpice. (2023) Influence of Hemorrhagic Complications of Pancreatoduodenectomy in Patients with Cancer on Short- and Long-Term Mortality. Journal of Clinical Medicine 12:8, pages 2852.
Crossref
Crossref
Anthony M. Villano, Karen Ruth, Jason Castellanos, Jeffrey M. Farma & Sanjay S. Reddy. (2023) Discrepancies in survival after conversion to open in minimally invasive pancreatoduodenectomy. The American Journal of Surgery 225:4, pages 728-734.
Crossref
Crossref
Colin S. Hill & Joseph M. Herman. (2023) The Current Role of Radiation in Pancreatic Cancer and Future Directions. Clinical Colorectal Cancer 22:1, pages 12-23.
Crossref
Crossref
Amira Kohil, Sayeda S. Amir, Axel Behrens & Omar M. Khan. (2023) A small Rho GTPase RAB25 with a potential role in chemotherapy resistance in pancreatic cancer. Cancer Biomarkers 36:2, pages 133-145.
Crossref
Crossref
Nemanja Djokovic, Ana Djuric, Dusan Ruzic, Tatjana Srdic-Rajic & Katarina Nikolic. (2023) Correlating Basal Gene Expression across Chemical Sensitivity Data to Screen for Novel Synergistic Interactors of HDAC Inhibitors in Pancreatic Carcinoma. Pharmaceuticals 16:2, pages 294.
Crossref
Crossref
Qiang Zhang, Yubao Tang, Shuai Sun, Qiuyi Xie, Jie Yao, Xiaodong Wang, Jianjun Qian & Zhennan Li. (2022) An extensive bioinformatics study on the role of mitochondrial solute carrier family 25 in PC and its mechanism behind affecting immune infiltration and tumor energy metabolism. Journal of Translational Medicine 20:1.
Crossref
Crossref
Manoj Amrutkar, Caroline S. Verbeke, Anette Vefferstad Finstadsveen, Linda Dorg, Knut Jørgen Labori & Ivar P. Gladhaug. (2022) Neoadjuvant chemotherapy is associated with an altered metabolic profile and increased cancer stemness in patients with pancreatic ductal adenocarcinoma. Molecular Oncology.
Crossref
Crossref
Wade Christopher, Sean Nassoiy, Rebecca Marcus, Jennifer Keller, Shu-Ching Chang, Trevan Fischer, Anton Bilchik & Melanie Goldfarb. (2022) Neoadjuvant chemotherapy improves outcomes in resectable pancreatic adenocarcinoma. Surgery in Practice and Science 11, pages 100136.
Crossref
Crossref
Yubin Pan, Honglin Tang, Qijun Li, Guangpeng Chen & Da Li. (2022) Exosomes and their roles in the chemoresistance of pancreatic cancer. Cancer Medicine 11:24, pages 4979-4988.
Crossref
Crossref
Monica Chase, Howard S Friedman, Seongjung Joo & Prakash Navaratnam. (2022) Adjuvant and neoadjuvant treatment patterns among resectable pancreatic cancer patients in the USA. Future Oncology 18:35, pages 3929-3939.
Crossref
Crossref
Hao Cheng, Jun Yang, Xu Fu, Liang Mao, Xuehui Chu, Chenglin Lu, Gang Li, Yudong Qiu & Wei He. (2022) Folate receptor-positive circulating tumor cells predict survival and recurrence patterns in patients undergoing resection for pancreatic cancer. Frontiers in Oncology 12.
Crossref
Crossref
Justin A. Drake, Andrew M. Fleming, Stephen W. Behrman, Evan S. Glazer, Jeremiah L. Deneve, Danny Yakoub, Miriam W. Tsao & Paxton V. Dickson. (2022) Tumor Location in the Pancreatic Tail Is Associated with Decreased Likelihood of Receiving Chemotherapy for Pancreatic Adenocarcinoma. Journal of Gastrointestinal Surgery 26:10, pages 2136-2147.
Crossref
Crossref
Takashi Yamamichi, Junji Ichinose, Kenshiro Omura, Kohei Hashimoto, Yosuke Matsuura, Masayuki Nakao, Sakae Okumura, Norihiko Ikeda & Mingyon Mun. (2022) Impact of postoperative complications on the long-term outcome in lung cancer surgery. Surgery Today 52:9, pages 1254-1261.
Crossref
Crossref
Wei Ding, Yuxu Wang, Yongbiao Ma, Li Lin & Manjiang Li. (2022) Identification of Candidate Therapeutic Target Genes and Profiling of Tumor-Infiltrating Immune Cells in Pancreatic Cancer via Integrated Transcriptomic Analysis. Disease Markers 2022, pages 1-14.
Crossref
Crossref
Sean Nassoiy, Wade Christopher, Rebecca Marcus, Jennifer Keller, Jessica Weiss, Shu-Ching Chang, Richard Essner, Leland Foshag, Trevan Fischer & Melanie Goldfarb. (2022) Evolving management of early stage pancreatic adenocarcinoma in older patients. The American Journal of Surgery.
Crossref
Crossref
Karenia Landa, Robin Schmitz, Norma E. Farrow, Christel Rushing, Donna Niedzwiecki, Marcelo Cerullo, Garth S. Herbert, Kevin N. Shah, Sabino Zani, Dan G. BlazerIIIIII, Peter J. Allen & Michael E. Lidsky. (2022) Surgical resection is associated with improved long-term survival of patients with resectable pancreatic head cancer compared to multiagent chemotherapy. HPB 24:7, pages 1153-1161.
Crossref
Crossref
Weikun Xiao, Mahsa Pahlavanneshan, Chae-Young Eun, Xinyu Zhang, Charlene DeKalb, Bayan Mahgoub, Hanaa Knaneh-Monem, Sana Shah, Alireza Sohrabi, Stephanie K. Seidlits & Reginald Hill. (2022) Matrix stiffness mediates pancreatic cancer chemoresistance through induction of exosome hypersecretion in a cancer associated fibroblasts-tumor organoid biomimetic model. Matrix Biology Plus 14, pages 100111.
Crossref
Crossref
Wei Zhang, Lichen Ji, Xugang Zhong, Senbo Zhu, Yi Zhang, Meng Ge, Yao Kang & Qing Bi. (2022) Two Novel Nomograms Predicting the Risk and Prognosis of Pancreatic Cancer Patients With Lung Metastases: A Population-Based Study. Frontiers in Public Health 10.
Crossref
Crossref
Tomas Koltai, Stephan Joel Reshkin, Tiago M. A. Carvalho, Daria Di Molfetta, Maria Raffaella Greco, Khalid Omer Alfarouk & Rosa Angela Cardone. (2022) Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review. Cancers 14:10, pages 2486.
Crossref
Crossref
Marina Roy-Luzarraga, Louise E. Reynolds, Beatriz de Luxán-Delgado, Oscar Maiques, Laura Wisniewski, Emma Newport, Vinothini Rajeeve, Rebecca J.G. Drake, Jesús Gómez-Escudero, Frances M. Richards, Céline Weller, Christof Dormann, Ya-Ming Meng, Peter B. Vermeulen, Dieter Saur, Victoria Sanz-Moreno, Ping-Pui Wong, Cyrill Géraud, Pedro R. Cutillas & Kairbaan Hodivala-Dilke. (2022) Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment. Cancer Research 82:10, pages 1909-1925.
Crossref
Crossref
Knut Jørgen Labori. (2022) Short-Course or Total Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic Cancer - Current Status and Future Perspectives. Frontiers in Surgery 9.
Crossref
Crossref
Susann Theile, Julia Sidenius Johansen, Dorte Lisbet Nielsen, Benny Vittrup Jensen, Carsten Palnæs Hansen, Jane Preuss Hasselby, Sverrir Vídalín Eiríksson & Inna Markovna Chen. (2022) A Randomized Placebo-Controlled Phase 2 Study of Gemcitabine and Capecitabine with or without T-ChOS as Adjuvant Therapy in Patients with Resected Pancreatic Cancer (CHIPAC). Pharmaceutics 14:3, pages 509.
Crossref
Crossref
William A. Hall, Laura A. Dawson, Theodore S. Hong, Manisha Palta, Joseph M. Herman, Douglas B. Evans, Susan Tsai, Cristina R. Ferrone, Jason B. Fleming, Daniel T. Chang, Christopher Crane, Albert C. Koong, Andrew Oar, Parag Parikh, Beth Erickson, Sarah Hoffe & Karyn A. Goodman. (2021) Value of Neoadjuvant Radiation Therapy in the Management of Pancreatic Adenocarcinoma. Journal of Clinical Oncology 39:34, pages 3773-3777.
Crossref
Crossref
Sung Hwan Lee, Ho Kyoung Hwang, Woo Jung Lee & Chang Moo Kang. (2021) MCT4 as a potential therapeutic target to augment gemcitabine chemosensitivity in resected pancreatic cancer. Cellular Oncology 44:6, pages 1363-1371.
Crossref
Crossref
Sijia Sun, Min Jo Kim, Ashraf M. Omar, Nguyen Duy Phan & Suresh Awale. (2021) (+)-Panduratin A induces PANC-1 human pancreatic cancer cell death preferentially under nutrient starvation by inhibiting PI3K/Akt/mTOR/autophagy signaling pathway. Phytomedicine Plus 1:4, pages 100101.
Crossref
Crossref
Jaewoo Kwon, Seo Young Park, Yejong Park, Eunsung Jun, Woohyung Lee, Ki Byung Song, Jae Hoon Lee, Dae Wook Hwang & Song Cheol Kim. (2020) A comparison of minimally invasive vs open distal pancreatectomy for resectable pancreatic ductal adenocarcinoma: Propensity score matching analysis. Journal of Hepato-Biliary-Pancreatic Sciences 28:11, pages 967-982.
Crossref
Crossref
Aditi Jain & Vikas Bhardwaj. (2021) Therapeutic resistance in pancreatic ductal adenocarcinoma: Current challenges and future opportunities. World Journal of Gastroenterology 27:39, pages 6527-6550.
Crossref
Crossref
Michal Eid, Paraskevi Karousi, Lumír Kunovský, Štěpán Tuček, Dagmar Brančíková, Zdeněk Kala, Ondřej Slabý, Jiří Mayer, Christos K. Kontos & Jan Trna. (2021) The Role of Circulating MicroRNAs in Patients with Early-Stage Pancreatic Adenocarcinoma. Biomedicines 9:10, pages 1468.
Crossref
Crossref
Nedal Bukhari, Khalda Abdalla, Fahad Ibnshamsa, Waleed Alselwi, Shakir Al-Shakir & Mohammed Alqahtani. (2021) Exceptional Response to Second-Line Gemcitabine/Nab-Paclitaxel Chemotherapy in Patients With Metastatic Pancreatic Adenocarcinoma. Cureus.
Crossref
Crossref
Yuki Fujii, Hirofumi Kamachi, Fumihiko Matsuzawa, Tatsuzo Mizukami, Nozomi Kobayashi, Moto Fukai & Akinobu Taketomi. (2021) Early administration of amatuximab, a chimeric high-affinity anti-mesothelin monoclonal antibody, suppresses liver metastasis of mesothelin-expressing pancreatic cancer cells and enhances gemcitabine sensitivity in a xenograft mouse model. Investigational New Drugs 39:5, pages 1256-1266.
Crossref
Crossref
Caroline J. Rieser, Sowmya Narayanan, Nathan Bahary, David L. Bartlett, Kenneth K. Lee, Alessandro Paniccia, Kenneth Smith & Amer H. Zureikat. (2021) Optimal management of patients with operable pancreatic head cancer: A Markov decision analysis. Journal of Surgical Oncology 124:5, pages 801-809.
Crossref
Crossref
Mingyi Shang, Li Weng, Guifang Xu, Shaoqiu Wu, Bingyan Liu, Xiang Yin, Aiwu Mao, Xiaoping Zou & Zhongmin Wang. (2021) TRIM11 suppresses ferritinophagy and gemcitabine sensitivity through UBE2N/TAX1BP1 signaling in pancreatic ductal adenocarcinoma. Journal of Cellular Physiology 236:10, pages 6868-6883.
Crossref
Crossref
Kennedy Yao Yi Ng, Edwin Wei Xiang Chow, Bochao Jiang, Cindy Lim, Brian Kim Poh Goh, Ser Yee Lee, Jin Yao Teo, Damien Meng Yew Tan, Peng Chung Cheow, London Lucien Peng Jin Ooi, Pierce Kah Hoe Chow, Joycelyn Jie Xin Lee, Juinn Huar Kam, Ye Xin Koh, Prema Raj Jeyaraj, Ek Khoon Tan, Su Pin Choo, Chung Yip Chan, Alexander Yaw Fui Chung & David Tai. (2021) Resected pancreatic adenocarcinoma: An Asian institution's experience. Cancer Reports 4:5.
Crossref
Crossref
Xing-Yu Liu, Chuan-Hao Guo, Zhi-Yuan Xi, Xin-Qi Xu, Qing-Yang Zhao, Li-Sha Li & Ying Wang. (2021) Histone methylation in pancreatic cancer and its clinical implications. World Journal of Gastroenterology 27:36, pages 6004-6024.
Crossref
Crossref
Sijia Sun, Min Jo Kim, Ashraf M. Omar, Nguyen Duy Phan, Mio Aoike & Suresh Awale. (2021) GDP Induces PANC‐1 Human Pancreatic Cancer Cell Death Preferentially under Nutrient Starvation by Inhibiting PI3K/Akt/mTOR/Autophagy Signaling Pathway. Chemistry & Biodiversity 18:9.
Crossref
Crossref
Liqiong Yang, Yun Bai, Qing Li, Jie Chen, Fangfang Liu, Xiechuan Weng & Fan Xu. (2021) Analysis of the Curative Effect of Neoadjuvant Therapy on Pancreatic Cancer. Frontiers in Oncology 11.
Crossref
Crossref
Panagiotis Sarantis, Alexandros Bokas, Adriana Papadimitropoulou, Evangelos Koustas, Stamatios Theocharis, Pavlos Papakotoulas, Dimitrios Schizas, Alexandros Papalampros, Evangelos Felekouras, Athanasios G. Papavassiliou & Michalis V. Karamouzis. (2021) Combinatorial Treatment of Tinzaparin and Chemotherapy Can Induce a Significant Antitumor Effect in Pancreatic Cancer. International Journal of Molecular Sciences 22:13, pages 7053.
Crossref
Crossref
Alvaro Gregorio Morales Taboada, Pablo Lozano Lominchar, Lorena Martin Roman, Pilar García-Alfonso, Andres Jesús Muñoz Martin, Jose Antonio Blanco Rodriguez & Jose Manuel Asencio Pascual. (2021) Advances in neoadjuvant therapy for resectable pancreatic cancer over the past two decades. Annals of Hepato-Biliary-Pancreatic Surgery 25:2, pages 179-191.
Crossref
Crossref
Iman M. Ahmad, Alicia J. Dafferner, Kelly A. O’Connell, Kamiya Mehla, Bradley E. Britigan, Michael A. Hollingsworth & Maher Y. Abdalla. (2021) Heme Oxygenase-1 Inhibition Potentiates the Effects of Nab-Paclitaxel-Gemcitabine and Modulates the Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma. Cancers 13:9, pages 2264.
Crossref
Crossref
Elizabeth J. Olecki, Kelly Stahl, June S. Peng, Matthew Dixon, Niraj J. Gusani & Chan Shen. (2020) Undertreatment of Pancreatic Cancer: Role of Surgical Pathology. Annals of Surgical Oncology 28:3, pages 1581-1592.
Crossref
Crossref
Zijian Wu, Jin Xu, Chen Liang, Qingcai Meng, Jie Hua, Wei Wang, Bo Zhang, Jiang Liu, Xianjun Yu & Si Shi. (2021) Emerging roles of the solute carrier family in pancreatic cancer. Clinical and Translational Medicine 11:3.
Crossref
Crossref
Harald Hugenschmidt, Knut Jørgen Labori, Elin Borgen, Cathrine Brunborg, Cecilie Bendigtsen Schirmer, Lars Thomas Seeberg, Bjørn Naume & Gro Wiedswang. (2021) Preoperative CTC-Detection by CellSearch® Is Associated with Early Distant Metastasis and Impaired Survival in Resected Pancreatic Cancer. Cancers 13:3, pages 485.
Crossref
Crossref
Yejong Park, Hye Ryeong Jun, Hwi Wan Choi, Dae Wook Hwang, Jae Hoon Lee, Ki Byung Song, Woohyung Lee, Jaewoo Kwon, Su Hyeon Ha, Eunsung Jun & Song Cheol Kim. (2021) Circulating tumour cells as an indicator of early and systemic recurrence after surgical resection in pancreatic ductal adenocarcinoma. Scientific Reports 11:1.
Crossref
Crossref
Sen Yu, Chunyu Zhang & Ke-Ping Xie. (2021) Therapeutic resistance of pancreatic cancer: Roadmap to its reversal. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1875:1, pages 188461.
Crossref
Crossref
Knut Jørgen Labori, Kjetil Søreide & Svein Dueland. 2021. Textbook of Pancreatic Cancer. Textbook of Pancreatic Cancer
697
712
.
Manoj Amrutkar, Nils Tore Vethe, Caroline S. Verbeke, Monica Aasrum, Anette Vefferstad Finstadsveen, Petra Sántha & Ivar P. Gladhaug. (2020) Differential Gemcitabine Sensitivity in Primary Human Pancreatic Cancer Cells and Paired Stellate Cells Is Driven by Heterogenous Drug Uptake and Processing. Cancers 12:12, pages 3628.
Crossref
Crossref
Jesse V. Groen, Tom A. Douwes, Elizabeth van Eycken, Lydia G. M. van der Geest, Tom B. Johannesen, Marc G. Besselink, Bas Groot Koerkamp, Johanna W. Wilmink, Bert A. Bonsing, Johanna E. A. Portielje, Cornelus J. H. van de Velde, Esther Bastiaannet & J. Sven D. Mieog. (2020) Treatment and Survival of Elderly Patients with Stage I–II Pancreatic Cancer: A Report of the EURECCA Pancreas Consortium. Annals of Surgical Oncology 27:13, pages 5337-5346.
Crossref
Crossref
Harald Hugenschmidt, Knut Jørgen Labori, Cathrine Brunborg, Caroline Sophie Verbeke, Lars Thomas Seeberg, Cecilie Bendigtsen Schirmer, Anne Renolen, Elin Borgen, Bjørn Naume & Gro Wiedswang. (2020) Cytokeratin-positive cells in the bone marrow from patients with pancreatic, periampullary malignancy and benign pancreatic disease show no prognostic information. BMC Cancer 20:1.
Crossref
Crossref
Minoru Oshima, Keiichi Okano, Hironobu Suto, Yasuhisa Ando, Hideki Kamada, Tsutomu Masaki, Shigeo Takahashi, Toru Shibata & Yasuyuki Suzuki. (2020) Changes and prognostic impact of inflammatory nutritional factors during neoadjuvant chemoradiotherapy for patients with resectable and borderline resectable pancreatic cancer. BMC Gastroenterology 20:1.
Crossref
Crossref
Justin A. Drake, Zachary E. Stiles, Stephen W. Behrman, Evan S. Glazer, Jeremiah L. Deneve, Bradley G. Somer, Noam A. Vanderwalde & Paxton V. Dickson. (2020) The utilization and impact of adjuvant therapy following neoadjuvant therapy and resection of pancreatic adenocarcinoma: does more really matter?. HPB 22:11, pages 1530-1541.
Crossref
Crossref
Hao Liu, Mazen S. Zenati, Caroline J. Rieser, Amr Al-Abbas, Kenneth K. Lee, Aatur D. Singhi, Nathan Bahary, Melissa E. Hogg, Herbert J. ZehIIIIII & Amer H. Zureikat. (2020) CA19-9 Change During Neoadjuvant Therapy May Guide the Need for Additional Adjuvant Therapy Following Resected Pancreatic Cancer. Annals of Surgical Oncology 27:10, pages 3950-3960.
Crossref
Crossref
Friedrich Anger, Anna Döring, Julia Schützler, Christoph-Thomas Germer, Volker Kunzmann, Nicolas Schlegel, Johan F. Lock, Armin Wiegering, Stefan Löb & Ingo Klein. (2020) Prognostic impact of simultaneous venous resections during surgery for resectable pancreatic cancer. HPB 22:10, pages 1384-1393.
Crossref
Crossref
Aslam R. Syed, Neil M. Carleton, Zachary Horne, Annika Dhawan, Gurneet Bedi, Gursimran Kochhar, Suzanne Morrissey, Harry Williams, Donald Atkinson, Suzanne Schiffman, Dulabh Monga, Anthony Lupetin, Alexander Kirichenko, Marcia Mitre, Manish Dhawan, Abhijit Kulkarni & Shyam Thakkar. (2019) Survival Trends for Resectable Pancreatic Cancer Using a Multidisciplinary Conference: the Impact of Post-operative Chemotherapy. Journal of Gastrointestinal Cancer 51:3, pages 836-843.
Crossref
Crossref
Selena S. Li, Brooks V. Udelsman, Aparna Parikh, Samuel J. Klempner, Jeffrey W. Clark, Eric J. Roeland, Jennifer Y. Wo, Theodore S. Hong & John T. Mullen. (2020) Impact of Postoperative Complication and Completion of Multimodality Therapy on Survival in Patients Undergoing Gastrectomy for Advanced Gastric Cancer. Journal of the American College of Surgeons 230:6, pages 912-924.
Crossref
Crossref
Harald Hugenschmidt, Knut Jørgen Labori, Cathrine Brunborg, Caroline Sophie Verbeke, Lars Thomas Seeberg, Cecilie Bendigtsen Schirmer, Anne Renolen, Elin Faye Borgen, Bjørn Naume & Gro Wiedswang. (2020) Circulating Tumor Cells are an Independent Predictor of Shorter Survival in Patients Undergoing Resection for Pancreatic and Periampullary Adenocarcinoma. Annals of Surgery 271:3, pages 549-558.
Crossref
Crossref
Antonio Galvano, Marta Castiglia, Sergio Rizzo, Nicola Silvestris, Oronzo Brunetti, Giovanni Vaccaro, Valerio Gristina, Nadia Barraco, Marco Bono, Giovanni Guercio, Giuseppa Graceffa, Fabio Fulfaro, Stefania Gori, Viviana Bazan & Antonio Russo. (2020) Moving the Target on the Optimal Adjuvant Strategy for Resected Pancreatic Cancers: A Systematic Review with Meta-Analysis. Cancers 12:3, pages 534.
Crossref
Crossref
Abdullah K. Malik, Angela Lamarca, Ajith Kumar Siriwardena, Derek O'Reilly, Rahul Deshpande, Thomas Satyadas, Saurabh Jamdar, Aali Sheen, Mairead McNamara, Richard Hubner, Juan Valle & Nicola De Liguori Carino. (2020) The Influence of Patients' Age on the Outcome of Treatment for Pancreatic Ductal Adenocarcinoma. Pancreas 49:2, pages 201-207.
Crossref
Crossref
Tara M. Mackay, F. Jasmijn Smits, Daphne Roos, Bert A. Bonsing, Koop Bosscha, Olivier R. Busch, Geert-Jan Creemers, Ronald M. van Dam, Casper H.J. van Eijck, Michael F. Gerhards, Jan Willem B. de Groot, Bas Groot Koerkamp, Nadia Haj Mohammad, Erwin van der Harst, Ignace H.J.T. de Hingh, Marjolein Y.V. Homs, Geert Kazemier, Mike S.L. Liem, Vincent E. de Meijer, I. Quintus Molenaar, Vincent B. Nieuwenhuijs, Hjalmar C. van Santvoort, George P. van der Schelling, Martijn W.J. Stommel, Albert Jan ten Tije, Judith de Vos-Geelen, Fennie Wit, Johanna W. Wilmink, Hanneke W.M. van Laarhoven & Marc G. Besselink. (2020) The risk of not receiving adjuvant chemotherapy after resection of pancreatic ductal adenocarcinoma: a nationwide analysis. HPB 22:2, pages 233-240.
Crossref
Crossref
Manoj Amrutkar, Emma Kristine Larsen, Monica Aasrum, Anette Vefferstad Finstadsveen, Per Arne Andresen, Caroline S. Verbeke & Ivar P. Gladhaug. (2020) Establishment and Characterization of Paired Primary Cultures of Human Pancreatic Cancer Cells and Stellate Cells Derived from the Same Tumor. Cells 9:1, pages 227.
Crossref
Crossref
Rossana Berardi, Silvia Rinaldi, Giulio Belfiori, Stefano Partelli, Stefano Crippa, Mariangela Torniai & Massimo Falconi. (2020) The Role of Hyponatraemia Before Surgery in Patients With Radical Resected Pancreatic Cancer. Clinical Medicine Insights: Oncology 14, pages 117955492093660.
Crossref
Crossref
Alice C. Wei, Fang-Shu Ou, Qian Shi, Xiomara Carrero, Eileen M. O’Reilly, Jeffrey Meyerhardt, Robert A. Wolff, Hedy L. Kindler, Douglas B. Evans, Vikram Deshpande, Joseph Misdraji, Eric Tamm, Dushyant Sahani, Malcolm Moore, Elliot Newman, Nipun Merchant, Jordan Berlin, Laura W. Goff, Peter Pisters & Mitchell C. Posner. (2019) Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial. Annals of Surgical Oncology 26:13, pages 4489-4497.
Crossref
Crossref
Vandana Sandhu, Knut Jorgen Labori, Ayelet Borgida, Ilinca Lungu, John Bartlett, Sara Hafezi-Bakhtiari, Robert E. Denroche, Gun Ho Jang, Danielle Pasternack, Faridah Mbaabali, Matthew Watson, Julie Wilson, Elin H. Kure, Steven Gallinger & Benjamin Haibe-Kains. (2019) Meta-Analysis of 1,200 Transcriptomic Profiles Identifies a Prognostic Model for Pancreatic Ductal Adenocarcinoma. JCO Clinical Cancer Informatics:3, pages 1-16.
Crossref
Crossref
Manoj Amrutkar, Monica Aasrum, Caroline S. Verbeke & Ivar P. Gladhaug. (2019) Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells. BMC Cancer 19:1.
Crossref
Crossref
Oneda & Zaniboni. (2019) Are We Sure that Adjuvant Chemotherapy is the Best Approach for Resectable Pancreatic Cancer? Are We in the Era of Neoadjuvant Treatment? A Review of Current Literature. Journal of Clinical Medicine 8:11, pages 1922.
Crossref
Crossref
Ariella M. Altman, Keith Wirth, Schelomo Marmor, Emil Lou, Katherine Chang, Jane Y. C. Hui, Todd M. Tuttle, Eric H. Jensen & Jason W. Denbo. (2019) Completion of Adjuvant Chemotherapy After Upfront Surgical Resection for Pancreatic Cancer Is Uncommon Yet Associated With Improved Survival. Annals of Surgical Oncology 26:12, pages 4108-4116.
Crossref
Crossref
M Tanaka, A L Mihaljevic, P Probst, M Heckler, U Klaiber, U Heger, M W Büchler & T Hackert. (2019) Meta-analysis of recurrence pattern after resection for pancreatic cancer. British Journal of Surgery 106:12, pages 1590-1601.
Crossref
Crossref
Zeng, Pöttler, Lan, Grützmann, Pilarsky & Yang. (2019) Chemoresistance in Pancreatic Cancer. International Journal of Molecular Sciences 20:18, pages 4504.
Crossref
Crossref
Bart M.G. Baekelandt, Morten W. Fagerland, Marianne J. Hjermstad, Turid Heiberg, Knut J. Labori & Trond A. Buanes. (2019) Survival, Complications and Patient Reported Outcomes after Pancreatic Surgery. HPB 21:3, pages 275-282.
Crossref
Crossref
Michał Piątek, Katarzyna Kuśnierz, Michał Bieńkowski, Rafał Pęksa, Marek Kowalczyk & Sergiusz Nawrocki. (2019) Primarily resectable pancreatic adenocarcinoma – to operate or to refer the patient to an oncologist?. Critical Reviews in Oncology/Hematology 135, pages 95-102.
Crossref
Crossref
Tessa Ya Sung Le Large, Btissame El Hassouni, Niccola Funel, Bart Kok, Sander R. Piersma, Thang V. Pham, Kenneth P. Olive, Geert Kazemier, Hanneke W.M. van Laarhoven, Connie R. Jimenez, Maarten F. Bijlsma & Elisa Giovannetti. (2019) Proteomic analysis of gemcitabine-resistant pancreatic cancer cells reveals that microtubule-associated protein 2 upregulation associates with taxane treatment. Therapeutic Advances in Medical Oncology 11, pages 175883591984123.
Crossref
Crossref
Daishi MorimotoSuguru YamadaKenta Murotani, Fuminori SonoharaHideki TakamiMasaya SuenagaMasamichi HayashiYukiko NiwaMitsuru TashiroNorifumi HattoriNaoki IwataMitsuro KandaChie TanakaDaisuke KobayashiGoro NakayamaMasahiko KoikeMichitaka FujiwaraTsutomu FujiiYasuhiro Kodera. (2018) Prognostic Impact of Portal System Invasion in Pancreatic Cancer Based on Image Classification. Pancreas 47:10, pages 1350-1356.
Crossref
Crossref
Alicia Eubanks, Julie Pepe, Paula Veldhuis & Sebastian G. de la Fuente. (2018) Age as a prognostic indicator for adjuvant therapy in patients who underwent pancreatic resections for cancer. Journal of Geriatric Oncology 9:4, pages 362-366.
Crossref
Crossref
Timothy J. Vreeland & Mathew H.G. Katz. (2018) Timing of Pancreatic Resection and Patient Outcomes. Surgical Clinics of North America 98:1, pages 57-71.
Crossref
Crossref
Susanna W. L. de Geus, Gyulnara G. Kasumova, Mariam F. Eskander, Sing Chau Ng, Tara S. Kent, A. James Moser, Alexander L. Vahrmeijer, Mark P. Callery & Jennifer F. Tseng. (2017) Is Neoadjuvant Therapy Sufficient in Resected Pancreatic Cancer Patients? A National Study. Journal of Gastrointestinal Surgery 22:2, pages 214-225.
Crossref
Crossref
Savio George Barreto. 2018. Surgical Diseases of the Pancreas and Biliary Tree. Surgical Diseases of the Pancreas and Biliary Tree
427
469
.
Knut Jørgen Labori, Kristoffer Lassen, Dag Hoem, Jon Erik Grønbech, Jon Arne Søreide, Kim Mortensen, Rune Smaaland, Halfdan Sorbye, Caroline Verbeke & Svein Dueland. (2017) Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) – study protocol for a national multicentre randomized controlled trial. BMC Surgery 17:1.
Crossref
Crossref
Manoj Amrutkar & Ivar Gladhaug. (2017) Pancreatic Cancer Chemoresistance to Gemcitabine. Cancers 9:12, pages 157.
Crossref
Crossref
Vegard Tjomsland, Monica Aasrum, Thoralf Christoffersen & Ivar P Gladhaug. (2017) Functional heterogeneity in tumor-derived human pancreatic stellate cells: Differential expression of HGF and implications for mitogenic signaling and migration in pancreatic cancer cells. Oncotarget 8:42, pages 71672-71684.
Crossref
Crossref
D Kleive, M A Sahakyan, A E Berstad, C S Verbeke, I P Gladhaug, B Edwin, B Fosby, P-D Line & K J Labori. (2017) Trends in indications, complications and outcomes for venous resection during pancreatoduodenectomy. British Journal of Surgery 104:11, pages 1558-1567.
Crossref
Crossref
A.S. Guerard, A. Ayav, H. Busby, M. Lafitte, H. Rousseau & V. Laurent. (2017) Early liver metastases in resectable periampullary cancer: Incidence and risk factors. European Journal of Radiology 93, pages 265-272.
Crossref
Crossref
Stefan Heinrich & Hauke Lang. (2017) Neoadjuvant Therapy of Pancreatic Cancer: Definitions and Benefits. International Journal of Molecular Sciences 18:8, pages 1622.
Crossref
Crossref
Hari Nathan, Huiying Yin & Sandra L. Wong. (2016) Postoperative Complications and Long-Term Survival After Complex Cancer Resection. Annals of Surgical Oncology 24:3, pages 638-644.
Crossref
Crossref
Susanna W.L. de Geus, Mariam F. Eskander, Lindsay A. Bliss, Gyulnara G. Kasumova, Sing Chau Ng, Mark P. Callery & Jennifer F. Tseng. (2017) Neoadjuvant therapy versus upfront surgery for resected pancreatic adenocarcinoma: A nationwide propensity score matched analysis. Surgery 161:3, pages 592-601.
Crossref
Crossref
Trond A Buanes. (2017) Role of surgery in pancreatic cancer. World Journal of Gastroenterology 23:21, pages 3765.
Crossref
Crossref
Jason W. Denbo & Jason B. Fleming. 2017. Pancreatic Cancer. Pancreatic Cancer
139
149
.
Jason W. Denbo & Jason B. Fleming. (2016) Definition and Management of Borderline Resectable Pancreatic Cancer. Surgical Clinics of North America 96:6, pages 1337-1350.
Crossref
Crossref
Vegard Tjomsland, Eva Pomianowska, Monica Aasrum, Dagny Sandnes, Caroline Sophie Verbeke & Ivar Prydz Gladhaug. (2016) Profile of MMP and TIMP Expression in Human Pancreatic Stellate Cells: Regulation by IL-1α and TGFβ and Implications for Migration of Pancreatic Cancer Cells. Neoplasia 18:7, pages 447-456.
Crossref
Crossref
Jason C. Maggi, Melissa E. Hogg, Amer H. Zureikat & Herbert J. Zeh. (2016) Update on the Management of Pancreatic Cancer: Determinants for Surgery and Widening the Therapeutic Window of Surgical Resection. Current Surgery Reports 4:7.
Crossref
Crossref
Trond A Buanes. (2016) Updated therapeutic outcome for patients with periampullary and pancreatic cancer related to recent translational research. World Journal of Gastroenterology 22:48, pages 10502.
Crossref
Crossref